David M Vail (David Vail)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum

Basal Cell Carcinoma

Top Venues

Veterinary and comparative oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marilia Takada, Keita Kitagawa, Yongzhen Zhang, Jürgen B Bulitta, Steven Moirano, Abigail Jones, Jennifer Borgen, Ashley Onsager, Tuddow Thaiwong, David M Vail
Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial. Veterinary and comparative oncology (2024)
Marilia Takada, Keita Kitagawa, Yongzhen Zhang, Jürgen B Bulitta, Steven Moirano, Abigail Jones, Jennifer Borgen, Ashley Onsager, Tuddow Thaiwong, David M Vail
Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial. Veterinary and comparative oncology 22 (3) (2024)
Amy K LeBlanc, Christina N Mazcko, Timothy M Fan, David M Vail, Brian K Flesner, Jeffrey N Bryan, Shan Li, Feng Wang, Scott Harris, Jesse D Vargas, Jeevan P Govindharajulu, Soumya Jaganathan, Francesca Tomaino, Apurva K Srivastava, Tsui-Fen Chou, Gordon M Stott, Joseph M Covey, Barbara Mroczkowski, James H Doroshow
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs. Molecular cancer therapeutics 21 (10) (2022)
Kara Magee, Ian R Marsh, Michelle M Turek, Joseph Grudzinski, Eduardo Aluicio-Sarduy, Jonathan W Engle, Ilene D Kurzman, Cindy L Zuleger, Elizabeth A Oseid, Christine Jaskowiak, Mark R Albertini, Karla Esbona, Bryan Bednarz, Paul M Sondel, Jamey P Weichert, Zachary S Morris, Reinier Hernandez, David M Vail
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PloS one 16 (8) (2021)
Amy K LeBlanc, Christina N Mazcko, Aswini Cherukuri, Erika P Berger, William C Kisseberth, Megan E Brown, Susan E Lana, Kristen Weishaar, Brian K Flesner, Jeffrey N Bryan, David M Vail, Jenna H Burton, Jennifer L Willcox, Anthony J Mutsaers, J Paul Woods, Nicole C Northrup, Corey Saba, Kaitlin M Curran, Haley J Leeper, Heather Wilson-Robles, Brandan Wustefeld Janssens, Stephanie Lindley, Annette N Smith, Nikolaos Dervisis, Shawna Klahn, Mary Lynn Higginbotham, Raelene M Wouda, Erika Krick, Jennifer A Mahoney, Cheryl A London, Lisa G Barber, Cheryl E Balkman, Angela L McCleary-Wheeler, Steven E Suter, Olya Martin, Antonella Borgatti, Kristine E Burgess, Michael O Childress, Janean L Fidel, Sara D Allstadt, Daniel L Gustafson, Laura E Selmic, Chand Khanna, Timothy M Fan
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Ravi B Patel, Reinier Hernandez, Peter M Carlson, Joseph Grudzinski, Amber M Bates, Justin C Jagodinsky, Amy Erbe, Ian R Marsh, Ian Arthur, Eduardo Aluicio-Sarduy, Raghava N Sriramaneni, Won Jong Jin, Christopher Massey, Alexander L Rakhmilevich, David M Vail, Johnathan W Engle, Trang Le, KyungMann Kim, Bryan P Bednarz, Paul M Sondel, Jamey Weichert, Zachary S Morris
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science translational medicine 13 (602) (2021)